New UCL-developed immunotherapy shows promising results in treating bone cancer
Bone cancer affects more than 150,000 people in the UK and is often resistant to chemotherapy
Read More
Tag: OPS-gdT
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
